Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v4-FR
Language French French
Date Updated 2020-10-26 2019-02-15
Drug Identification Number 02440296 02440296
Brand name NAT-ESCITALOPRAM NAT-ESCITALOPRAM
Common or Proper name Escitalopram Tablets Escitalopram Tablets
Company Name NATCO PHARMA (CANADA) INC NATCO PHARMA (CANADA) INC
Ingredients ESCITALOPRAM ESCITALOPRAM
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code N06AB N06AB
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Requirements related to complying with good manufacturing practices. Shortage of an active ingredient.
Anticipated start date 2019-06-30 2019-06-30
Actual start date
Estimated end date Unknown Unknown
Actual end date 2020-10-05
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments